INTERNATIONAL PATENT: SANOFI BIOTECHNOLOGY FILES APPLICATION FOR "DIFFERENTIAL BIOMARKERS FOR ANTI-INTERLEUKIN-6 AND ANTI-TUMOR NECROSIS FACTOR-Α TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS"

GENEVA, March 9 -- SANOFI BIOTECHNOLOGY (82 avenue Raspail94250 GENTILLY) filed a patent application (PCT/EP2025/074660) for "DIFFERENTIAL BIOMARKERS FOR ANTI-INTERLEUKIN-6 AND ANTI-TUMOR NECROSIS FACTOR-Α TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS" on Aug 29, 2025. With publication no. WO/2026/047197, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AGUEUSOP, Inoncent (c/o Sanofi-Aventis Deutschland GmbH,65926 Frankfurt am Main), BIESEMANN, Nadine (c/o Sanofi-Aventis Deutschland GmbH65926 Frankfurt am Main)

Abstract...